What is the recommended treatment approach for Amniopatch (amniotic sac repair) during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amniopatch for Amniotic Sac Repair

Direct Answer

Amniopatch—the infusion of autologous platelet concentrate followed by cryoprecipitates to repair premature rupture of membranes—is an experimental technique with limited evidence that may be considered in select cases of second-trimester iatrogenic membrane rupture, though no formal guidelines currently recommend this approach and outcomes remain highly variable. 1

What is Amniopatch?

Amniopatch involves the intrauterine infusion of autologous platelet concentrate followed by cryoprecipitates to restore the amnio-chorial link interrupted by membrane rupture. 1 The technique aims to physiologically facilitate the natural repair process and seal the membrane defect. 1

Clinical Context and Outcomes

Reported Experience

  • Amniopatch has been attempted primarily for iatrogenic membrane rupture following amniocentesis (occurring in 0.8-1% of procedures between 15-18 weeks gestation) and spontaneous premature rupture of membranes (PROM) in the second trimester. 1
  • In a small case series of 5 patients treated between 17-23 weeks gestation, complete closure with restoration of normal amniotic fluid occurred in 2 cases (40%), while incomplete closure occurred in 3 cases (60%). 1
  • Neonatal outcomes were highly variable: 3 cases had acceptable outcomes (deliveries at 41,32, and 27 weeks), 1 case was complicated by brain hemorrhage, and 1 case resulted in abortion. 1

Critical Limitations

The evidence base consists of isolated case reports and small case series with no randomized controlled trials, no formal guideline recommendations, and highly inconsistent outcomes. 1 The technique remains experimental and is not part of standard obstetric practice.

Alternative Management Approaches

For Iatrogenic Membrane Rupture

When membrane rupture occurs following amniocentesis or other procedures, standard management typically involves:

  • Expectant management with close surveillance for infection, oligohydramnios, and preterm labor
  • Serial ultrasound assessment of amniotic fluid volume
  • Consideration of prophylactic antibiotics (though not universally recommended)
  • Delivery planning based on gestational age at rupture and subsequent complications

For Prolapsed Amniotic Sac with Cervical Dilation

Emergency operative closure of the cervix (EOCC) with or without cerclage has been reported for cases of early cervical dilation with prolapsed amniotic sac between 15-28 weeks gestation. 2 In a series of 16 patients with cervical dilation of 2-8 cm, EOCC (with or without cerclage) after antibiotic and tocolytic treatment achieved mean delivery at 33 weeks, with 14 of 16 fetuses surviving healthy. 2 The best results were obtained with EOCC plus cerclage. 2

Key Considerations

When Amniopatch Might Be Considered

  • Second-trimester iatrogenic membrane rupture with documented amniotic fluid leak
  • Absence of infection or active labor
  • Patient counseling regarding experimental nature and variable outcomes
  • Availability of technical expertise and resources

Absolute Contraindications

  • Active intrauterine infection or chorioamnionitis
  • Advanced labor that cannot be arrested
  • Fetal anomalies incompatible with life
  • Maternal coagulopathy or bleeding disorders (relative contraindication given use of platelet concentrate)

Critical Pitfalls to Avoid

  • Do not present amniopatch as standard or evidence-based therapy—it remains experimental with no guideline support and highly variable outcomes. 1
  • Do not delay appropriate obstetric management (such as delivery at viable gestational ages with complications) while pursuing experimental membrane repair techniques.
  • Do not attempt amniopatch without comprehensive informed consent discussing the lack of established efficacy, potential risks, and alternative management strategies.
  • Do not overlook signs of infection—chorioamnionitis remains a major risk after membrane rupture and requires prompt delivery regardless of gestational age.

Practical Algorithm

  1. Confirm membrane rupture with sterile speculum exam, nitrazine/fern testing, or ultrasound documentation of oligohydramnios
  2. Assess gestational age and fetal viability
  3. Rule out infection with maternal temperature, white blood cell count, C-reactive protein, and clinical assessment
  4. Determine etiology: iatrogenic (post-procedure) versus spontaneous PROM
  5. For second-trimester cases without infection:
    • Standard approach: Expectant management with surveillance
    • Experimental approach: Consider amniopatch only after extensive counseling, in research settings, or when standard management has failed
  6. For cases with cervical dilation and prolapsed sac: Consider emergency cervical cerclage after infection and labor are controlled 2
  7. Serial monitoring: Weekly or twice-weekly ultrasound for fluid volume, biophysical profile, and signs of infection
  8. Delivery planning: Based on gestational age, fluid status, and maternal-fetal condition

References

Related Questions

What is the management for a pregnant patient at 22 weeks gestation with a history of dilation and curettage (D&C) for retained placenta, current cerclage, and evidence of posterior uterine wall dehiscence and amniotic sac outpouching?
What is the initial management for a patient with no fluids and no pain meds?
What are some evidenced-based free online resources for patients with Attention Deficit Hyperactivity Disorder (ADHD)?
What diagnosis is used to order a DEXA (Dual-Energy X-ray Absorptiometry) bone density scan for a patient with prostate cancer on LHRH (Luteinizing Hormone-Releasing Hormone) agonist therapy?
How to treat orthostatic hypotension?
What is the recommended use and dosage of Rinvoq (upadacitinib) for patients with rheumatoid arthritis, psoriatic arthritis, or atopic dermatitis?
What is the recommended starting dose of calcitriol (Vitamin D3) for a patient with secondary hyperparathyroidism due to chronic kidney disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question